M&A Deal Summary

MLM Medical Labs Acquires MD Biosciences

On October 27, 2020, MLM Medical Labs acquired life science company MD Biosciences

Acquisition Highlights
  • This is MLM Medical Labs’ 2nd transaction in the Life Science sector.
  • This is MLM Medical Labs’ 2nd transaction in the United States.
  • This is MLM Medical Labs’ 1st transaction in Minnesota.

M&A Deal Summary

Date 2020-10-27
Target MD Biosciences
Sector Life Science
Buyer(s) MLM Medical Labs
Deal Type Add-on Acquisition

Target

MD Biosciences

Oakdale, Minnesota, United States
MD Biosciences, Inc. is a provider of preclinical, translational, and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. MD Biosciences was established in 1991 and is based in Oakdale, Minnesota.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MLM Medical Labs

Mönchengladbach, Germany

Category Company
Founded 1993
Sector Life Science
DESCRIPTION

MLM Medical Labs offers a full range of laboratory services, including specialized biomarker testing, clinical chemistry, standard safety profiles, and analyses of drug compounds, metabolites and molecular diagnostic parameters. MLM Medical Labs was founded in 1993 and is headquartered in Moenchengladbach, Germany.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Minnesota M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-09 CirQuest Labs

Memphis, Tennessee, United States

CirQuest Labs provides the highest standards of life science services to the pharmaceutical and implantable device industries. CirQuest provides specialized assay development, biomarker testing, and central lab services to its global client base of leading pharmaceutical and life sciences companies.

Buy -